Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses
Authors:
- Marwa SaadMSMarwa Saad
- Alexandra ThomsATAlexandra Thoms
- Yue S. YinYYYue S. Yin
- Izabela MamedeIMIzabela Mamede
- Afsana RahmanARAfsana Rahman
- Ruonan ChenRCRuonan Chen
- Sebastián E. CarrascoSCSebastián E. Carrasco
- Patrick W. DarcyPDPatrick W. Darcy
- Norihiro GotoNGNorihiro Goto
- Sohail F. TavazoieSTSohail F. Tavazoie
- Angelina M. BilateABAngelina M. Bilate
- Daniel MucidaDMDaniel Mucida
- 26 October 2026
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 224 (1)
Abstract
Colorectal cancer (CRC) remains a leading cause of mortality, with most cases refractory to immunotherapy. Distinguishing tumor-induced from steady-state mucosal T cell responses represents a critical barrier to understanding CRC immunity. Using orthotopic transplantation of CRC organoids with and without metastatic potential, combined with T cell fate-mapping, we show that nonmetastatic tumors elicit early recruitment of CD8αβ+ and CD4+ T cells with cytotoxic and Th1-like programs, whereas pro-metastatic (pro-Met) tumors induce a naïve-like, hypoactivated state. Tumor-infiltrating CD4+ T cells underwent clonal expansion, including clones recognizing microbial and dietary antigens. T cells physically interacting with tumors, identified by universal LIPSTIC, were enriched for expanded and cytotoxic clones. Fate-mapped T cells from nonmetastatic tumors suppressed tumor growth in an IFN-γ–dependent manner. Mechanistically, pro-Met tumors downregulated MHCII, and Ciita targeting in nonmetastatic organoids reduced CD4+ clonal expansion and led to tumor progression. Together, these findings define divergent early T cell trajectories associated with CRC metastasis, indicating that ineffective local immune engagement precedes metastatic dissemination.Keywords
Funding Information
- National Institutes of Health (P30 CA008748-59)
- National Institutes of Health (R01DK093674)
- National Institutes of Health (R01DK113375)
- National Institutes of Health (U54CA261701)
- Chan Zuckerberg Initiative
- Weill Cancer Hub East
- Howard Hughes Medical Institute
This publication has 75 references indexed in Scilit:
- The hallmarks of cancer immune evasionCancer Cell, 2024
- Functional genetic screen identifies ITPR3/calcium/RELB axis as a driver of colorectal cancer metastatic liver colonizationDevelopmental Cell, 2022
- Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancerImmunity, 2021
- T Cell Receptor Is Required for Differentiation, but Not Maintenance, of Intestinal CD4+ Intraepithelial LymphocytesImmunity, 2020
- Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated TumorigenesisCell Reports, 2020
- Tuft-Cell-Derived Leukotrienes Drive Rapid Anti-helminth Immunity in the Small Intestine but Are Dispensable for Anti-protist ImmunityImmunity, 2020
- Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific ImmunityImmunity, 2020
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite InstabilityImmunity, 2016
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic ActivityCell, 2015
- A genetic model for colorectal tumorigenesisCell, 1990